CARDIORENAL SYNDROME IN CHRONIC HEART FAILURE: PATHOGENESIS, DIAGNOSTICS, PROGNOSIS AND OPPORTUNITIES FOR TREATMENT
https://doi.org/10.15829/1560-4071-2017-1-136-141
Abstract
The review focuses on cardiorenal syndrome developing in patients with chronic heart failure. The specifics of pathogenesis is discussed, as diagnostics and prognosis, with emphasis on the opportunities of modern biomarker strategy. The complicated cardiorenal issues are discussed and perspectives of their further exploration for treatment tactics in cohort of heart failure patients.
About the Authors
E. A. Medvedeva
Federal Almazov North-West Medical Research Centre of the Ministry of Health;
Samara State Medical University of the Ministry of Health
Russian Federation
Russian Federation
Saint-Petersburg;
Samara
N. V. Shilyaeva
Federal Almazov North-West Medical Research Centre of the Ministry of Health;
Samara State Medical University of the Ministry of Health
Russian Federation
Russian Federation
Saint-Petersburg;
Samara
E. N. Iskhakov
Federal Almazov North-West Medical Research Centre of the Ministry of Health;
Samara State Medical University of the Ministry of Health
Russian Federation
Russian Federation
Saint-Petersburg;
Samara
Yu. V. Schukin
Federal Almazov North-West Medical Research Centre of the Ministry of Health;
Samara State Medical University of the Ministry of Health
Russian Federation
Russian Federation
Saint-Petersburg;
Samara
References
1. Ronco C, House AA, Haapio M. Cardiorenal syndrome: refining the definition of a complex symbiosis gone wrong. Intensive Care Med 2008; 34(5): 957-62.
2. McAlister FA, Ezekowitz J, Tarantini L, et al. Renal dysfunction in patients with heart failure with preserved versus reduced ejection fraction: impact of the new Chronic Kidney Disease-Epidemiology Collaboration Group formula. Circ Heart Fail 2012; 5: 309-314 [PMID:22441773 doi: 10.1161/circheartfailure.111.966242].
3. Valente MA, Hillege HL, Navis G, et al. The Chronic Kidney Disease Epidemiology Collaboration equation outperforms the Modification of Diet in Renal Disease equation for estimating glomerular filtration rate in chronic systolic heart failure. Eur J Heart Fail 2014; 16: 86-94 [PMID: 23901055 DOI:10.1093/eurjhf/hft128].
4. Matsushita K, Mahmoodi BK, Woodward M, et al. Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA 2012; 307: 1941-51 [PMID: 22570462 DOI: 10.1001/jama.2012.3954].
5. Cruz DN, Fard A, Clementi A, et al. Role of Biomarkers in the Diagnosis and Management of Cardio-Renal syndromes. Seminars in Nephrology 2012; 32(1): 79-92. doi:10.1016/j.semnephrol.2011.11.011.
6. Damman K, van Veldhuisen DJ, Navis G, et al. Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate. Heart. 2010; 96: 1297-302.
7. Masson S, Latini R, Milani V, et al. Prevalence and prognostic value of elevated urinary albumin excretion in patients with chronic heart failure: data from the GISSI-Heart Failure trial. Circ Heart Fail 2010; 3: 65-72 [PMID: 19850697 DOI: 10.1161/CIRCHEARTFAILURE].
8. Shlipak MG, Mattes MD, Peralta CA. Update on cystatin C: incorporation into clinical practice. Am J Kidney Dis 2013; 62: 595-603 [PMID: 23701892 DOI: 10.1053/j.ajkd.2013.03.027].
9. Tang WH, Van Lente F, Shrestha K, et al. Impact of myocardial function on cystatin C measurements in chronic systolic heart failure. J Card Fail 2008; 14: 394-9. [PMID: 18514931 DOI: 10.1016/j.cardfail.2008.01.006].
10. Lassus JP, Nieminen MS, Peuhkurinen K, et al. Markers of renal function and acute kidney injury in acute heart failure: definitions and impact on outcomes of the cardio-renal syndrome. Eur Heart J. 2010; 31: 2791-8.
11. Rubattu S, Mennuni S, Testa M, et al. Pathogenesis of chronic cardiorenal syndrome: is there a role of oxidative stress? Int.J.Mol.Sci. 2013, 14, 23011-32; doi:10.3390|ijms141123011.
12. Waldum-Grevbo B. What Physicians Need to Know About Renal Function in Outpatients with Heart Failure. Cardiology 2015; 131: 130-8. doi: 10.1159/000381012.
13. Damman K, Voors AA, Navis G, et al. The сardiorenal syndrome in heart failure. Prog Cardiovasc Dis 2011; 54: 144-53.
14. McCullough PA, Kellum JA, Mehta RL, et al. ADQI Consensus on AKI Biomarkers and Cardiorenal Syndromes. Basel, Karger 2013; 182: 117-36. DOI: 10.1159/000349968.
15. Lekawanvijit S, Kompa AR, Zhang Y, et al. Myocardial infarction impair renal function, induces renal interstitial fibrosis, and increase renal KIM-1 expression: implications for cardiorenal syndrome. AmJ Physiol Heart Circ Phusiol 2012; 302: H1884-H1893.
16. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2016. European heart journal doi: 10.1093/eurheartj/ehw128.
17. Minasyan AM Use of statins in cardiorenal syndrome: possibilities for its treatment and prevention. Clinicist 2012; 3-4: 80-4. Russian (Минасян А.М. Применение статинов при кардиоренальном синдроме: возможности лечения и профилактики. Клиницист 2012; 3-4: 80-4).
18. Cardiovascular risk and chronic kidney disease: strategy of cardiac and nephronprotection Russ J Cardiol 2014; 112(8): 7-37. Russian (Сердечно-сосудистый риск и хроническая болезнь почек: стратегии кардио-нефропротекции. Российский кардиологический журнал 2014; 112(8): 7-37).
19. Zamora E, Lupon J, Vila J, et al. Estimated glomerular filtration rate and prognosis in heart failure: value of the Modification of Diet in Renal Disease Study-4, chronic kidney disease epidemiology collaboration, and cockroft-gault formulas. J Am Coll Cardio. 2012; 59: 1709-15. doi:10.1016/j.jacc.2011.11.066.
20. Dupont M, Wu Y, Hazen SL, et al. Cystatin С identifies patients with stable chronic heart failure at increased risk for adverse cardiovascular events. Circ Heart Fail. 2012; 5(5): 602-9. doi:10.1161/CIRCHEARTFAILURE.112.966960.
21. Zamora E, Lupón J, de Antonio M, et al. A long-term prognostic value for patients with chronic heart failure of estimated glomerular filtration rate calculated with the new CKD-EPI equations containing Cystatin C. Clin Chem. 2014; 60(3): 481-9; doi:10.1373/clinchem.2013.212951.
22. Jackson CE, Solomon SD, Gerstein HC, et al. Albuminuria in chronic heart failure: prevalence and prognostic importance. Lancet 2009; 374: 543-50; doi:10.1016/S0140-6736(09)61378-7.
23. Damman K, Masson S, Hillege HL, et al. Clinical outcome of renal tubular damage in chronic heart failure. Eur Heart J. 2011, 32: 2705-12; doi:10.1093/eurheartj/ehr190.
24. van Deursen VM, Damman K, Voors AA, et al. Prognostic value of plasma neutrophil gelatinase–associated lipocalin for mortality in patients with heart failure. Circ Heart Fail. 2014; 7: 35-42; doi:10.1161/CIRCHEARTFAILURE.113.000242.
25. Ennezat PV, Maréchaux S, Six-Carpentier M, et al. Renal resistance index and its prognostic significance in patients with heart failure with preserved ejection fraction. Nephrol Dial Transplant. 2011; 26: 3908-13; doi:10.1093/ndt/gfr116.
26. Ciccone MM, Iacoviello M, Gesualdo L, et al. The renal arterial resistance index: a marker of renal function with an independent and incremental role in predicting heart failure progression. Eur J Heart Fail. 2014; 16: 210-216; doi:10.1002/ejhf.34.
Supplementary files
|
1. Рисунок 1 | |
| Subject | ||
| Type | Рисунок | |
Download
(97KB)
|
Indexing metadata ▾ | |
|
2. Титульный лист | |
| Subject | ||
| Type | титульный лист | |
Download
(12KB)
|
Indexing metadata ▾ | |
|
|
3. Направление | |
| Subject | ||
| Type | Направительное письмо | |
View
(481KB)
|
Indexing metadata ▾ | |
Review
For citations:
Medvedeva E.A., Shilyaeva N.V., Iskhakov E.N., Schukin Yu.V. CARDIORENAL SYNDROME IN CHRONIC HEART FAILURE: PATHOGENESIS, DIAGNOSTICS, PROGNOSIS AND OPPORTUNITIES FOR TREATMENT. Russian Journal of Cardiology. 2017;(1):136-141. (In Russ.) https://doi.org/10.15829/1560-4071-2017-1-136-141
Views:
1993
Email this article 